Exponent, Inc.
Every calculator, already run for EXPO
Open the full toolkit →You have the numbers on EXPO. Get the argument.
A written report on which of these readings actually decide the outcome for Exponent, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
4 analysts covering EXPOAnalyst Price Target Disagreement for Exponent, Inc.
Wall Street's bull case implies +40% from the current price; the bear case implies +12%. Analysts are relatively aligned on EXPO's range.
Ownership & short interest
Insider Trading Activity for EXPO
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Exponent, Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regu…
EXPO — frequently asked
Is EXPO a buy right now?
Wall Street's consensus rating on Exponent, Inc. is none across 4 analysts, with a mean price target of $84.00 (+31% vs. the current $64.18). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is EXPO overvalued?
EXPO trades at 28.8x trailing earnings, against a DCF fair value of $42 per share. The current price implies 11% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is EXPO's next earnings date?
Exponent, Inc. is next scheduled to report earnings around Oct 29, 2026. A full EXPO research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Exponent, Inc.?
Analysts covering Exponent, Inc. (EXPO) range from a bear-case target of $72.00 to a bull-case high of $90.00, with a mean consensus target of $84.00 across 3 analysts. The spread of $18.00 (28% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Exponent, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Exponent, Inc.
Start with the evergreen guides that matter most for Industrials, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full EXPO research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Exponent, Inc., in minutes. 3 free reports included with every account — no credit card required.